文献速递其他结缔组织病自身炎症与 IgG4 相关病

全身型幼年特发性关节炎不同炎症表型的分子特征

Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis.
PubMed 文献 · Ann Rheum Dis · 2019-04-20

研究旨在识别全身型幼年特发性关节炎(SJIA)不同疾病阶段的生物标志物。将活动期SJIA患儿按临床分为全身炎症型(SJIA syst)和多关节型(SJIA poly),发现队列每组10例加感染10例,验证队列SJIA syst 45例、SJIA poly 29例、感染32例,采用LC-MS/MS和靶向检测。结果可区分两种表型,靶向MRM联合免疫检测正确识别91%(SJIA syst vs SJIA poly)和77%(SJIA syst vs 感染)的病例。

要点

  • SJIA全身型与多关节型存在可区分的分子特征,提示双相疾病免疫过程转变。
  • 生物标志物特征可辅助早期区分SJIA全身炎症期与感染。
  • 表型转换标志物可能为达标治疗策略提供信息。

核心结论

  • 识别出区分SJIA两种表型的分子特征,提示双相疾病中免疫过程发生转变。
  • 区分SJIA初始自身炎症期与主要鉴别诊断感染的特征有助于早期诊断决策。
  • 表型转换标志物可为达标治疗策略提供信息。

研究设计与样本

  • 发现队列:活动期SJIA每组10例,另感染10例,采用非靶向LC-MS/MS和免疫检测筛查。
  • 验证队列:SJIA syst 45例、SJIA poly 29例、感染32例,采用MRM-MS和靶向免疫检测。

主要发现

  • LC-MS/MS在发现队列中能较好区分SJIA syst与SJIA poly,但与感染区分效果较差。
  • 靶向MRM验证了发现数据,联合靶向免疫检测正确识别91%(SJIA syst vs SJIA poly)和77%(SJIA syst vs 感染)的病例。

关键数值与推荐

  • SJIA syst与SJIA poly的靶向检测正确识别率为91%。
  • SJIA syst与感染的正确识别率为77%。

临床怎么用

  • 生物标志物特征可能辅助早期区分SJIA全身炎症期与感染。
  • 表型转换标志物可能指导达标治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The International League of Associations for Rheumatology classification criteria define systemic juvenile idiopathic arthritis (SJIA) by the presence of fever, rash and chronic arthritis. Recent initiatives to revise current criteria recognise that a lack of arthritis complicates making the diagnosis early, while later a subgroup of patients develops aggressive joint disease. The proposed biphasic model of SJIA also implies a 'window of opportunity' to abrogate the development of chronic arthritis. We aimed to identify novel SJIA biomarkers during different disease phases. METHODS: Children with active SJIA were subgrouped clinically as systemic autoinflammatory disease with fever (SJIA syst ) or polyarticular disease (SJIA poly ). A discovery cohort of n=10 patients per SJIA group, plus n=10 with infection, was subjected to unbiased label-free liquid chromatography mass spectrometry (LC-MS/MS) and immunoassay screens. In a separate verification cohort (SJIA syst , n=45; SJIA poly , n=29; infection, n=32), candidate biomarkers were measured by multiple reaction monitoring MS (MRM-MS) and targeted immunoassays. RESULTS: Signatures differentiating the two phenotypes of SJIA could be identified. LC-MS/MS in the discovery cohort differentiated SJIA syst from SJIA poly well, but less effectively from infection. Targeted MRM verified the discovery data and, combined with targeted immunoassays, correctly identified 91% (SJIA syst vs SJIA poly ) and 77% (SJIA syst vs infection) of all cases. CONCLUSIONS: Molecular signatures differentiating two phenotypes of SJIA were identified suggesting shifts in underlying immunological processes in this biphasic disease. Biomarker signatures separating SJIA in its initial autoinflammatory phase from the main differential diagnosis (ie, infection) could aid early-stage diagnostic decisions, while markers of a phenotype switch could inform treat-to-target strategies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Gohar F, McArdle A, Jones M, et al. Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2019. PMID: 31005900. doi:10.1136/annrheumdis-2019-215051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。